The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard
When we discuss bacterial infections, we often think of exotoxins—those soluble proteins actively secreted by bacteria—while overlooking endotoxins, which are more insidious but equally dangerous. Endotoxins are not released by bacteria; rather, they are natural components residing in the bacterial cell wall’s outer membrane. When bacteria die or lyse, they may release endotoxins, triggering a complex cascade of hyperinflammatory responses.
When endotoxins spiral out of control: Endotoxemia
Endotoxemia is not only an independent symptom but a pathophysiological syndrome. It is caused by the presence of large amounts of endotoxins in the bloodstream. Endotoxins can trigger the body’s immune system to release massive amounts of inflammatory cytokines, leading to a systemic inflammatory response. Mild cases may present symptoms such as fever, fatigue, and headache, while severe cases can lead to organ failure and even life-threatening conditions.
Endotoxemia is one of the core mechanisms leading to sepsis and septic shock. Endotoxins do not directly kill cells, but the chain reaction they set off can be lethal. They may lead to systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), coagulation disorders, cardiogenic shock, and more. These fatal complications are precisely what make endotoxemia so dangerous.
Three major molecular mechanisms of endotoxin-induced pathogenesis
Pyrogenicity
The human body is extremely sensitive to endotoxins; as little as 1ng/kg–5ng/kg can induce fever. As mentioned above, endotoxins cause fever by activating leukocytes and macrophages, leading to increased cytokine production, including IL-1, IL-6, and TNF-α. These pro-inflammatory cytokines serve as endogenous pyrogens, regulating the temperature-sensitive neurons in the central nervous system and stimulating body temperature elevation.
Leukocyte Response
After endotoxins enter the body, they cause a large number of leukocytes to adhere to capillary walls, leading to a sharp decline in circulating leukocyte counts. However, within the following few hours, endotoxins stimulate the bone marrow to release neutrophils into the bloodstream, causing leukocytosis, which typically peaks at 12-24 hours. This dynamic pattern of ‘initial decrease followed by increase’ is an important characteristic of endotoxin infection.
Disseminated Intravascular Coagulation (DIC)
This may be one of the most dangerous effects of endotoxins. Endotoxins promote TNF and IL-1 expression, inducing leukocyte extravasation and disrupting the balance between coagulation and anticoagulation, leading to thrombus formation. Meanwhile, platelet-activating factor (PAF) causes platelet aggregation. Simply put, endotoxins trigger the coagulation system, leading to blood clotting and disseminated intravascular coagulation (DIC). When DIC becomes severe, it can result in life-threatening shock.
Challenges facing scientific research
The dangers of endotoxins extend far beyond clinical settings, posing equally severe challenges to scientific research and pharmaceutical development. Endotoxins (LPS) can induce systemic inflammatory responses and neuroinflammation in animals, thereby interfering with experimental results and potentially rendering preclinical data invalid. Additionally, endotoxin-contaminated recombinant proteins may adversely affect cellular behaviour due to their immunostimulatory and cytotoxic properties.
Endotoxin is a common contaminant in protein production. Even trace amounts of endotoxin in recombinant proteins can trigger strong immune responses, interfere with experimental results, and compromise patient safety—this is particularly critical in sensitive applications such as immunology, cell and gene therapy, and vaccine production. Therefore, endotoxin-free proteins are essential for ensuring the accuracy, safety, and regulatory compliance of experiments in sensitive biological and pharmaceutical applications.
The solution: ProPure™ Endotoxin-Free Proteins
Sino Biological offers a robust solution to the endotoxin challenge: Excellence Built on Ultra-Low Endotoxin. Sino Biological’s Center for Bioprocessing (C4B) in Texas produces ProPure™ endotoxin-free proteins with levels below the quantification limit (BQL) (< 0.05 EU/mg), which exceed the industry standard (0.5 EU/mg according to USP <85>). Choosing ProPure™ proteins supports accurate experimental outcomes, enhances data reliability, and improves safety for pre-clinical animal studies, accurate cell assays, and detection assays.
We possess advanced technological processes and equipment, ensuring that ProPure™ proteins achieve endotoxin levels as low as 0.05 EU/mg, with some products reaching 0.01 EU/mg, meeting the demands of sensitive scientific and translational applications. Sino Biological’s rigorous quality control system ensures ultra-low endotoxin levels, providing researchers with reliable assurance.
